EMD Serono

REBIF

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

EMD Serono

Rebif HCPCS:

Q3028

HCPCS Code Descriptor:

Injection, interferon beta-1a, 1 mcg for subcutaneous use

Category:

Q Code

Rebif NDCs:

44087-0022-03, 44087-3322-01, 44087-0044-03, 44087-3344-01, 44087-0188-01

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Subcutaneous

Rebif CPT Codes:

Potential CPT administration codes for Rebif can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

44087-0022-03, 44087-3322-01, 44087-0044-03, 44087-3344-01

About Rebif:

REBIF is a Neurology drug manufactured by EMD Serono and administered via the Subcutaneous route of administration. The Q Code: Q3028 is aligned to the drug REBIF.

ACCESS PRICING AND MORE BY REGISTERING

Q3028 Added Date:

January 1, 2014

Q3028 Effective Date:

January 1, 2014

Q3028 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Rebif billing and coding information.
Rebif patient assistance information can be found through MS LifeLines at the URL: https://www.mslifelines.com/
REBIF prescribing information can be found at the link below:
Information regarding REBIF’s side effects can be found at MedlinePlus